Improved synthesis of fibroblast growth factor receptor inhibitor AZD4547
Peng-fei LUO,Xiao-hua WU,Li HAI,Yong WU
DOI: https://doi.org/10.14142/j.cnki.cn21-1313/r.2017.06.006
2017-01-01
Abstract:Pyrazole compound AZD4547 N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-5-yl)-4-((3R,5S)-3,5-dimethylpiperazin-yl) benzamide is a fibroblast growth factor receptor inhibitor,developed by AstraZeneca,for potential cancer oral therapy.In this paper,3-(3,5-dimethoxyphenyl) propionate was synthesized based on the reported route.In the presence of n-butyllithium,3-(3,5-dimethoxyphenyl) propionate reacted with acetonitrile to synthesize 5-(3,5-dimethoxybenzeneyl)-3-carbonyl-pentanenitrile,followed by cyclization with hydrazine hydrate to give 5-(3,5-dimethoxyphenyethyl)-1H-pyrazol-3-amine.At the same time,a new synthetic method by one-pot reaction to afford 5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-amine was found,in which potassium tert-butoxide was selected as the alkaline reagent.As a result,two-step method and one-pot reaction increased the yield from 42.0％ reported in the literature to 86.0％ and 54.0％,respectively.Combination of 4-((3S,5R)-3,5-dimethylpiperazin-1-yl) benzoate and 5-(3,5-dimethoxy-phenethyl)-1H-pyrazol-3-amine was promoted by Al(CH3)3,affording AZD4547.Finally,the total yield of AZD4547 was increased from 21.0％ reported in the literature to 54.0％ and 34.0％,respectively.The structures of the target compound and some important intermediates have been identified by 1H-NMR and MS.Moreover,the two-step method significantly improves the total yield of AZD4547,and the operation of one-pot reaction is simpler and the reaction conditions are more safe and gentle.